Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
One of the tougher issues a non-lawyer compliance officer faces is a challenge to their decisions and recommendations by other members of…
From - G2 Compliance Advisor
Background checks aren't just for spotting criminal records. Are you checking the Office of Inspector General's List of…
From - G2 Compliance Advisor
Violations of Medicare-related laws such as the Anti-Kickback Statute, self-referral law and the False Claims Act can cost…
From - G2 Compliance Advisor
Laboratories should encourage or even require their compliance professionals to obtain…